A cost-utility and budget impact analysis of the sunitinib risk-sharing scheme for the treatment of metastatic RCC and for advanced GIST after failure of imatinib

Home > Research Projects > Strategy 3 : HTA Research > A cost-utility and budget impact analysis of the sunitinib risk-sharing scheme for the treatment of metastatic RCC and for advanced GIST after failure of imatinib

Project Code

11-3-089-2557(1)

Research team

Researchers

Pritaporn Kingkaew, PhD.

Co - Researcher

Thanthima Suwanthawornkul

Kittiphong Thiboonboon

Project Details

Strategies

Strategy 3 : HTA Research

Project Status

Completed - 100%

Viewer: 3126

Publish date17 November 2014 08:33

Documents

Activity

Top

A cost-utility and budget impact analysis of the sunitinib risk-sharing scheme for the treatment of metastatic RCC and for advanced GIST after failure of imatinib

Project Code

Research team

Researchers

Co - Researcher

Project Details

Project Status

Documents

Activity

Menu

Follow Us On

Subscribe to our mailing list

HITAP เข้าสู่ระบบ

A cost-utility and budget impact analysis of the sunitinib risk-sharing scheme for the treatment of metastatic RCC and for advanced GIST after failure of imatinib

Project Code

Research team

Researchers

Co - Researcher

Project Details

Project Status

Documents

Activity

Menu

Follow Us On

Subscribe to our mailing list

Subscribe to our mailing list